Somnomed Ltd
ASX:SOM
Somnomed Ltd
ASX:SOM
Price:
0.25 AUD
16.28%
Market Closed
Updated:
May 14, 2024
Somnomed Ltd
Income from Continuing Operations
|
Somnomed Ltd
Income from Continuing Operations Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Income from Continuing Operations
-AU$10.5m
|
CAGR 3-Years
-153%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Income from Continuing Operations
-AU$19.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-11%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Income from Continuing Operations
-AU$4.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-166%
|
CAGR 10-Years
7%
|
|
|
Cochlear Ltd
ASX:COH
|
Income from Continuing Operations
AU$350.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
17%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Income from Continuing Operations
-AU$5.4m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-11%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Income from Continuing Operations
-AU$3.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Income from Continuing Operations?
Income from Continuing Operations
-10.5m
AUD
-10.5m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Income from Continuing Operations amounts to -10.5m AUD.
What is Somnomed Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-20%
-20%
Over the last year, the Income from Continuing Operations growth was -103%. The average annual Income from Continuing Operations growth rates for Somnomed Ltd have been -153% over the past three years , -20% over the past five years .
You don't have any saved screeners yet
